Research News for September 4, 2019
advertisement
- Anti-CD3 drug keeps diabetes at bay
- Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting (HTML)
- A Reinforcement Learning-Based Method for Management of Type 1 Diabetes: Exploratory Study (HTML)
- Position β57 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset (see also: Study shows type 1 diabetes early diagnosis may be possible)
- Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing
- New directions in incidence and prevalence of diagnosed diabetes in the USA
- Regulated hAAT Expression from a Novel rAAV Vector and Its Application in the Prevention of Type 1 Diabetes (HTML)
- Tear film substance P: A potential biomarker for diabetic peripheral neuropathy (HTML)
- Early visual field changes in patients with type 1 diabetes mellitus (HTML)
- Intervention in emotional abilities for adolescents with type 1 diabetes mellitus in a hospital setting: a study protocol for a randomised controlled trial (HTML)
- Co-morbidity of type 1 diabetes and endometriosis: bringing a new paradigm into focus (HTML)
- New Evidence of Exocrine Pancreatopathy in Pre-symptomatic and Symptomatic Type 1 Diabetes (HTML)
- Associations between circulating inflammatory markers, diabetes type and complications in youth (HTML)
- Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy (HTML)
- Serum copper profile in patients with type 1 diabetes in comparison to other metals (HTML)
- Subclinical Auditory Neural Deficits in Patients With Type 1 Diabetes Mellitus (HTML)
- Neonatal Near Miss among Newborns of Women with Type 1 Diabetes Mellitus (HTML)
- Altered motor dynamics in type 1 diabetes modulate behavioral performance (HTML)
- Consistency of plasma glucagon levels in patients with type 1 diabetes after a one-year period (HTML)
- Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes (HTML)
- Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)
